Session » Abstracts: Antiphospholipid Syndrome
- 2:00PM-3:30PM
-
Abstract Number: 1607
Autoantibodies to Transcription Factor a Mitochondria Link Mitochondrial Damage and Thrombosis in Systemic Lupus Erythematosus
- 2:00PM-3:30PM
-
Abstract Number: 1605
Complement Activation as a Marker of Thrombosis Risk in Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- 2:00PM-3:30PM
-
Abstract Number: 1604
First and Recurrent Thrombosis Risk After 4,454 Patient-Years of Follow-Up: Prospective Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- 2:00PM-3:30PM
-
Abstract Number: 1603
Infection-Associated Antiphospholipid Antibodies and Their Potential Role in Sepsis Outcomes
- 2:00PM-3:30PM
-
Abstract Number: 1608
Plasma Proteomic Profiling in Antiphospholipid Antibody-positive Patients with Different Clinical Phenotypes: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
- 2:00PM-3:30PM
-
Abstract Number: 1606
Purinergic Signaling as a Potential Therapeutic Target for APS Thromboinflammation